This imaging modality is based on the observation that almost all adenocarcinomas of the prostate gland express PSMA to which Glu-NH-CO-NH-Lys-(Ahx)-[68Ga(HBED-CC)] is able to bind with very high affinity [28, 29]. The gene discussed is FOLH1; the disease is adenocarcinoma.